Opelz G, Mickey MR, Terasaki PI: Influence of race on kidney transplant survival. Transpl Proceedings 1977; 9:137–42.
Relman AS. Race and end-stage renal disease [editorial]. New Engl J Med 1982; 306:1290–1.
Shapiro R, McCauley J, Scantlebury V, et al.: Effect of recipient race on waiting time for renal transplantation at the University of Pittsburgh. Transpl Proceedings 1993; 25:2458–9.
McDonald JC: Issues related to race in transplantation. Transpl Proceedings 1989; 21:3411–2; discussion 3–8.
Koyama H, Cecka JM: Race effects. Clin Transplants 1991; 269–80.
Geiger HJ: Race and health care—an American dilemma? N Engl J Med 1996; 335:815–16.
Held PJ, Pauly MV, Bovbjerg RR, Newmann J, Salvatierra O, Jr.: Access to kidney transplantation. Has the United States eliminated income and racial differences? Arch Intern Med 1988; 148:2594–600.
Levinsky NG, Rettig RA: The Medicare end-stage renal disease program. A report from the Institute of Medicine. N Engl J Med 1991; 324:1143–8.
Rettig AR, Levinsky GN: Kidney failure and the federal government. Committee for the Study of the Medicare ESRD Program, Division of Health Care Services, Institute of Medicine: National Academy of Sciences; 1991.
Gaber AO, First MR, Tesi RJ, et al..: Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation. Transpl 1998; 66:29–37.